세계의 출생전 DNA 시퀀싱 시장 보고서(2023년)

“Prenatal DNA Sequencing Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal dna sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal dna sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The prenatal dna sequencing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Genetic Diseases; Nonhereditary Diseases

• 2) By Application: Hemophilia; Down Syndrome; Cystic Fibrosis; Autism; DiGeorgre Syndrome; AIDS (Acquired Immunodeficiency Syndrome); Cancer; Other Applications

• 3) By End User: Academic Research; Clinical Research; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

• Companies Mentioned: Agilent Technologies Inc.; BGI Group; F. Hoffmann-La Roche; Illumina Inc.; Laboratory Corporation of America Holdings

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the prenatal dna sequencing market are Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Genomic Health Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences, Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, and Thermo Fisher Scientific Inc.

The global prenatal DNA sequencing market is expected to grow from $1.84 billion in 2022 to $2.09 billion in 2023 at a compound annual growth rate (CAGR) of 13.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The prenatal DNA sequencing market is expected to grow to $3.52 billion in 2027 at a CAGR of 13.9%.

The prenatal DNA sequencing market includes revenues earned by entities by providing services such as prenatal next-generation sequencing, whole genome sequencing, DNA extraction, DNA fragmentation, and data collection and sequence analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Prenatal DNA sequencing refers to a method of sequencing the DNA of an unborn baby by using the blood sample from the mother that helps to reveal the full genetic code of the unborn baby. It is used to detect fetal disorders or diseases.

North America was the largest region in the prenatal DNA sequencing market in 2022. The regions covered in the prenatal DNA sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of prenatal DNA sequencing are genetic diseases and nonhereditary diseases. Genetic diseases refer to any disorder or disease that is caused by mutations in one or more genes. DNA sequencing helps to determine whether a gene contains a mutation that causes a disorder. It is used in various applications such as hemophilia, down syndrome, cystic fibrosis, autism, DiGeorge syndrome, AIDS, cancer, and others by academic research, clinical research, hospitals and clinics, pharmaceutical and biotechnology companies, and other users.

The increasing prevalence of cancer is expected to propel the growth of the prenatal DNA sequencing market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. Prenatal DNA sequencing in cancer is used to detect fetal aneuploidy in maternal plasma and to identify cancer in the fetus. The sequencing reveals the inherited or germline DNA changes that raise a person's chance of developing cancer. For instance, according to Globocan, a Switzerland-based provider of a worldwide database of cancer incidence and mortality rates, in 2020, there were around 19.29 million new cancer cases, and the number of cancer cases in a 5-year span is estimated to be 50.55 million. Therefore, the prevalence of cancer is driving the prenatal DNA sequencing market.

Product innovation is a key trend gaining popularity in the prenatal DNA sequencing market. Major companies operating in the market are focused on developing innovative solutions to strengthen their market position. For instance, in November 2022, Juno Diagnostics, Inc., a US-based health technology company that democratizes access to valuable genetic information, launched the noninvasive prenatal screening test "Hazel". The test is uniquely designed with no risk of miscarriage, and it can be performed as early as 9 weeks into pregnancy by using a small amount of blood. It screens the pregnancy for common genetic conditions caused by extra or missing chromosomes, such as Down syndrome, Edwards syndrome, and Patau syndrome.

In November 2022, Myriad Genetics, Inc., a US-based provider of genetic testing and precision medicine acquired Gateway Genomics, LLC for an undisclosed amount. Myriad expects to expand and strengthen its portfolio of women's health products, as well as provide access to personalized genetic tests, with the combined resources of this acquisition. Gateway Genomics, LLC is a US-based personal genomics, and prenatal DNA company and a developer of consumer genetic tests.

The countries covered in the prenatal DNA sequencing market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The prenatal DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides prenatal DNA sequencing market statistics, including the prenatal DNA sequencing industry global market size, regional shares, competitors with a prenatal DNA sequencing market share, detailed prenatal DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal DNA sequencing industry. This prenatal DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Prenatal DNA Sequencing Market
• 4.2. Ukraine-Russia War Impact On Prenatal DNA Sequencing Market
• 4.3. Impact Of High Inflation On Prenatal DNA Sequencing Market

5. Prenatal DNA Sequencing Market Size And Growth

• 5.1. Global Prenatal DNA Sequencing Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Prenatal DNA Sequencing Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Prenatal DNA Sequencing Market Segmentation

• 6.1. Global Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Genetic Diseases
• Nonhereditary Diseases
• 6.2. Global Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hemophilia
• Down Syndrome
• Cystic Fibrosis
• Autism
• DiGeorgre Syndrome
• AIDS (Acquired Immunodeficiency Syndrome)
• Cancer
• Other Applications
• 6.3. Global Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Academic Research
• Clinical Research
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Other End Users

7. Prenatal DNA Sequencing Market Regional And Country Analysis

• 7.1. Global Prenatal DNA Sequencing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Prenatal DNA Sequencing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Prenatal DNA Sequencing Market

• 8.1. Asia-Pacific Prenatal DNA Sequencing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Prenatal DNA Sequencing Market

• 9.1. China Prenatal DNA Sequencing Market Overview
• 9.2. China Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Prenatal DNA Sequencing Market

• 10.1. India Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Prenatal DNA Sequencing Market

• 11.1. Japan Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Prenatal DNA Sequencing Market

• 12.1. Australia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Prenatal DNA Sequencing Market

• 13.1. Indonesia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Prenatal DNA Sequencing Market

• 14.1. South Korea Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Prenatal DNA Sequencing Market

• 15.1. Western Europe Prenatal DNA Sequencing Market Overview
• 15.2. Western Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Prenatal DNA Sequencing Market

• 16.1. UK Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Prenatal DNA Sequencing Market

• 17.1. Germany Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Prenatal DNA Sequencing Market

• 18.1. France Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Prenatal DNA Sequencing Market

• 19.1. Eastern Europe Prenatal DNA Sequencing Market Overview
• 19.2. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Prenatal DNA Sequencing Market

• 20.1. Russia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Prenatal DNA Sequencing Market

• 21.1. North America Prenatal DNA Sequencing Market Overview
• 21.2. North America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Prenatal DNA Sequencing Market

• 22.1. USA Prenatal DNA Sequencing Market Overview
• 22.2. USA Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Prenatal DNA Sequencing Market

• 23.1. South America Prenatal DNA Sequencing Market Overview
• 23.2. South America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Prenatal DNA Sequencing Market

• 24.1. Brazil Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Prenatal DNA Sequencing Market

• 25.1. Middle East Prenatal DNA Sequencing Market Overview
• 25.2. Middle East Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Prenatal DNA Sequencing Market

• 26.1. Africa Prenatal DNA Sequencing Market Overview
• 26.2. Africa Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Prenatal DNA Sequencing Market Competitive Landscape And Company Profiles

• 27.1. Prenatal DNA Sequencing Market Competitive Landscape
• 27.2. Prenatal DNA Sequencing Market Company Profiles
  • 27.2.1. Agilent Technologies Inc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. BGI Group
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. F. Hoffmann-La Roche
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Illumina Inc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Laboratory Corporation of America Holdings
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

29. Prenatal DNA Sequencing Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer